- De novo analysis of protein N-terminal sequence utilizing MALDI signal enhancing derivatization with Br signatureKim, Jong-Seo; Song, Jin-Su; Kim, Yongju; Park, Seung Bum; Kim, Hie-Joon, Analytical and Bioanalytical Chemistry, 2012, 402(5), 1911-1919
Cas no 90145-48-5 (5-Bromopyridine-2-carboxamide)
5-Bromopyridine-2-carboxamide Chemical and Physical Properties
Names and Identifiers
-
- 5-Bromopyridine-2-carboxamide
- 2-Pyridinecarboxamide,5-bromo
- 2-Pyridinecarboxamide,5-bromo-
- 5-Bromopicolinamide
- IPWPEOLXILHOLV-UHFFFAOYSA-N
- BCP29826
- SBB055622
- 5-bromo-pyridine-2-carboxylic acid amide
- BL003043
- AB0027457
- ST50326602
- W9289
- ST
- 5-Bromo-2-pyridinecarboxamide (ACI)
- 90145-48-5
- SB77869
- 5-BROMOPYRIDINE-2-CARBOXAMIDE 97%5-BROMOPICOLINAMIDE
- SY064801
- SDCCGSBI-0660197.P001
- MFCD04066715
- SCHEMBL157129
- Z1065600734
- CS-W022338
- DTXSID90352742
- J-517200
- AKOS002354397
- EN300-7050647
- DB-006994
- 5-Bromopicolinamide;5-Bromo-2-carbamoylpyridine;2-Pyridinecarboxamide,5-bromo
- AC-5076
- FS-2661
-
- MDL: MFCD04066715
- Inchi: 1S/C6H5BrN2O/c7-4-1-2-5(6(8)10)9-3-4/h1-3H,(H2,8,10)
- InChI Key: IPWPEOLXILHOLV-UHFFFAOYSA-N
- SMILES: O=C(C1C=CC(Br)=CN=1)N
Computed Properties
- Exact Mass: 199.95900
- Monoisotopic Mass: 199.959
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 10
- Rotatable Bond Count: 1
- Complexity: 140
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 56
- XLogP3: 0.8
Experimental Properties
- Density: 1.71
- Melting Point: 218-220
- Boiling Point: 329.1°Cat760mmHg
- Flash Point: 152.8°C
- Refractive Index: 1.613
- PSA: 55.98000
- LogP: 1.64330
5-Bromopyridine-2-carboxamide Security Information
- Hazard Statement: Irritant/Keep Cold
-
Hazardous Material Identification:
- Storage Condition:Keep cold
5-Bromopyridine-2-carboxamide Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Bromopyridine-2-carboxamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-RU685-250mg |
5-Bromopyridine-2-carboxamide |
90145-48-5 | 98% | 250mg |
138CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-RU685-1g |
5-Bromopyridine-2-carboxamide |
90145-48-5 | 98% | 1g |
240.0CNY | 2021-08-04 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-RU685-5g |
5-Bromopyridine-2-carboxamide |
90145-48-5 | 98% | 5g |
1328CNY | 2021-05-08 | |
| Matrix Scientific | 076499-1g |
5-Bromopyridine-2-carboxamide, 95+% |
90145-48-5 | 95+% | 1g |
$80.00 | 2023-09-08 | |
| Matrix Scientific | 076499-5g |
5-Bromopyridine-2-carboxamide, 95+% |
90145-48-5 | 95+% | 5g |
$277.00 | 2023-09-08 | |
| Matrix Scientific | 076499-10g |
5-Bromopyridine-2-carboxamide, 95+% |
90145-48-5 | 95+% | 10g |
$425.00 | 2023-09-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-RU685-200mg |
5-Bromopyridine-2-carboxamide |
90145-48-5 | 98% | 200mg |
72.0CNY | 2021-08-04 | |
| TRC | B686613-100mg |
5-Bromopicolinamide |
90145-48-5 | 100mg |
$ 64.00 | 2023-04-18 | ||
| TRC | B686613-250mg |
5-Bromopicolinamide |
90145-48-5 | 250mg |
$ 75.00 | 2023-04-18 | ||
| TRC | B686613-500mg |
5-Bromopicolinamide |
90145-48-5 | 500mg |
$ 110.00 | 2023-04-18 |
5-Bromopyridine-2-carboxamide Production Method
Production Method 1
1.2 Reagents: Hydrogen peroxide Solvents: Water ; rt; 1 h, rt
Production Method 2
- Structure-Guided Modification of Heterocyclic Antagonists of the P2Y14 ReceptorYu, Jinha; Ciancetta, Antonella ; Dudas, Steven; Duca, Sierra; Lottermoser, Justine; et al, Journal of Medicinal Chemistry, 2018, 61(11), 4860-4882
Production Method 3
1.2 Reagents: Piperidine ; 5 s, rt; 1 min, 4 °C; 0.5 h, 25 °C
- DNA-Compatible Cyanomethylation of (Hetero)aryl Halides or Triflates under a Tandem Reaction for DNA-Encoded Library SynthesisZhang, Jie; Wang, Lu; Ji, Qian; Liu, Fei, Organic Letters, 2023, 25(37), 6931-6936
Production Method 4
- An efficient hydration of nitriles with ruthenium-supported heterogeneous catalyst in water under moderate conditionsHussain, Muhammad Asif; Choi, Eun Ju; Maqbool, Adnan ; Atif, Muhammad; Zeb, Hassan ; et al, Journal of Industrial and Engineering Chemistry (Amsterdam, 2021, 99, 187-195
5-Bromopyridine-2-carboxamide Raw materials
5-Bromopyridine-2-carboxamide Preparation Products
5-Bromopyridine-2-carboxamide Suppliers
5-Bromopyridine-2-carboxamide Related Literature
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
Additional information on 5-Bromopyridine-2-carboxamide
Introduction to 5-Bromopyridine-2-carboxamide (CAS No. 90145-48-5)
5-Bromopyridine-2-carboxamide, with the CAS number 90145-48-5, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is a derivative of pyridine, a six-membered heterocyclic aromatic ring containing one nitrogen atom, and is characterized by the presence of a bromine atom and an amide group at specific positions. The unique structural features of 5-Bromopyridine-2-carboxamide make it an attractive candidate for various applications, particularly in the development of novel therapeutic agents.
The chemical structure of 5-Bromopyridine-2-carboxamide can be represented as C6H6BrN2O. The bromine atom at the 5-position and the amide group at the 2-position confer specific properties that are crucial for its biological activity and reactivity. The bromine substituent is known to enhance the lipophilicity of the molecule, which can improve its ability to cross biological membranes and reach target sites within cells. The amide group, on the other hand, provides a functional handle for further chemical modifications, making it a valuable scaffold for drug design.
In recent years, 5-Bromopyridine-2-carboxamide has been extensively studied for its potential therapeutic applications. One notable area of research is its use as a lead compound in the development of inhibitors for various enzymes and receptors. For instance, studies have shown that derivatives of 5-Bromopyridine-2-carboxamide exhibit potent inhibitory activity against kinases, which are key enzymes involved in signal transduction pathways and are often dysregulated in diseases such as cancer and inflammatory disorders.
A study published in the Journal of Medicinal Chemistry in 2021 reported the synthesis and biological evaluation of a series of 5-Bromopyridine-2-carboxamide-based compounds as selective inhibitors of Aurora kinases. Aurora kinases are serine/threonine kinases that play critical roles in cell division and are frequently overexpressed in various cancers. The researchers found that certain derivatives of 5-Bromopyridine-2-carboxamide demonstrated high selectivity and potency against Aurora A and B kinases, with IC50 values in the low nanomolar range. These findings highlight the potential of 5-Bromopyridine-2-carboxamide-based compounds as promising candidates for cancer therapy.
Beyond kinase inhibition, 5-Bromopyridine-2-carboxamide has also shown promise in other therapeutic areas. For example, research published in Bioorganic & Medicinal Chemistry Letters in 2020 explored the use of 5-Bromopyridine-2-carboxamide-derived compounds as modulators of G protein-coupled receptors (GPCRs). GPCRs are a large family of membrane receptors that mediate a wide range of physiological processes and are important targets for drug discovery. The study demonstrated that certain derivatives of 5-Bromopyridine-2-carboxamide exhibited agonist or antagonist activity against specific GPCRs, suggesting their potential utility in treating conditions such as cardiovascular diseases and neurological disorders.
The synthetic accessibility of 5-Bromopyridine-2-carboxamide is another factor contributing to its popularity in pharmaceutical research. Various synthetic routes have been developed to prepare this compound efficiently, allowing researchers to explore a wide range of structural modifications. One common approach involves the bromination of pyridine followed by amidation using appropriate reagents. This flexibility in synthesis enables the rapid generation of diverse analogs, which can be screened for improved pharmacological properties.
In addition to its therapeutic potential, 5-Bromopyridine-2-carboxamide has also been investigated for its use as a building block in supramolecular chemistry. Supramolecular assemblies formed from this compound have shown interesting properties such as self-assembly into well-defined nanostructures, which could have applications in materials science and nanotechnology. A study published in Chemical Communications in 2019 reported the formation of supramolecular gels using derivatives of 5-Bromopyridine-2-carboxamide strong>. These gels exhibited tunable mechanical properties and could be used as stimuli-responsive materials for various applications.
The environmental impact and safety profile of compounds like 5-Bromopyridine-2-carboxamide strong> are also important considerations in their development and application. Recent studies have focused on assessing the biodegradability and toxicity of these compounds to ensure their safe use in pharmaceuticals and other industries. Preliminary data suggest that properly designed derivatives of < strong > 5-Bromopyridine-2-carboxamide strong > exhibit favorable environmental profiles, although further research is needed to fully understand their long-term effects.
In conclusion, < strong > 5-Bromopyridine-2-carboxamide strong > (CAS No. 90145-48-5) is a versatile compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features make it an attractive scaffold for developing novel therapeutic agents targeting various diseases, including cancer and inflammatory disorders. Ongoing research continues to uncover new applications for this compound, highlighting its importance in modern drug discovery efforts.
90145-48-5 (5-Bromopyridine-2-carboxamide) Related Products
- 62150-46-3(4-bromopyridine-2-carboxamide)
- 845305-86-4(5-Bromo-N,N-dimethylpyridine-2-carboxamide)
- 196106-96-4(4-Bromo-1H-pyrrole-2-carboxamide)
- 668992-72-1(4-Bromopyridine-2,6-dicarboxamide)
- 845305-90-0(N-Isopropyl 5-bromopicolinamide)
- 845305-89-7(5-Bromo-N-propylpyridine-2-carboxamide)
- 848952-82-9(2-Pyridinecarboxylicacid, 5-bromo-, hydrazide)
- 875514-62-8(1,6-Naphthyridine-2-carboxamide,8-bromo-)
- 845305-87-5(N-Methyl 5-bromopicolinamide)
- 845305-88-6(N-Ethyl 5-bromopicolinamide)